-
India asks States to manage immunisation drives better
expresspharma
March 19, 2021
About 6.5 per cent of coronavirus vaccine doses in India are going to waste, health officials said, urging states to manage their immunisation drives better to optimise the use of what one called “this elixir-like precious commodity”.
-
Frontline charities sign open letter backing COVID-19 vaccination drive
pharmatimes
March 17, 2021
A partnership of frontline health charities has signed an open letter encouraging people with underlying conditions to book in for a COVID-19 vaccine.
-
Global Covid-19 Vaccination Roll-out causes delay to RhoVac's Phase IIb study
prnasia
March 09, 2021
RhoVac AB, a Swedish cancer immunotherapy company, announces today, March 8th , 2021, that its clinical phase IIb study, "BRaVac", in prostate cancer, will be somewhat further delayed as Covid-19 vaccinations are rolled out to the study population.
-
Chancellor pledges an extra £1.65bn for UK’s COVID-19 vaccination roll-out
pharmatimes
March 05, 2021
Chancellor Rishi Sunak has unveiled the government’s spending plans for 2021, with much focus given to boosting the economy as COVID-19 restrictions are expected to ease later in the year.
-
GSK Pharma rolls out multilingual peadiatric vaccine awareness campaign on Public app
expresspharma
March 04, 2021
The ad campaign seeks to educate caregivers of children on the importance of timely vaccination and maintenance of records.
-
Business optimism remains unchanged in February: Poll
pharmaceutical-technology
March 03, 2021
Global Covid-19 vaccination drives have renewed hopes for recovery, but businesses remain cautious over outlook.
-
Liability for COVID vaccines in India: Where does the buck stop?
expresspharma
March 02, 2021
A month into Indias country-wide vaccination drive that began in January 2021, and we have reportedly seen the death of 27 people already, including that of a 24-year-old medical intern, a mere 11 days after her vaccination.
-
CDC adds cetirizine as therapy for anaphylaxis after Covid-19 vaccination
pharmaceutical-technology
February 25, 2021
TerSera Therapeutics has announced the addition of cetirizine as adjunctive therapy to the Centers for Disease Control and Prevention (CDC) guidelines titled ‘Interim considerations: preparing for the potential management of anaphylaxis after Covid-19 ...
-
Vaccination offers consistent long term protection: Experts
expresspharma
February 23, 2021
Vaccination offers much stronger immune response than natural infection, and therefore is the key to controlling the spread of the disease.
-
250mn Europeans to be vaccinated with COMIRNATY® by the end of 2021
europeanpharmaceuticalreview
February 19, 2021
Pfizer and BioNTech have agreed to supply the European Union with 200 million additional doses of COMIRNATY in 2021, making the total 500 million doses.